In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Emerging therapies in heart failure
Session

Event : Heart Failure 2019

Topic : Chronic Heart Failure - Pathophysiology

  • Session type : Symposium
  • Date : 27 May 2019
  • Time : 16:30 - 18:00
  • Joint Session with the working group on pharmacotherapy of the ESC

7 presentations in this session

Drugs targeting cardiac metabolism.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : GMC Rosano (London,GB)
  • Joint Session with the working group on pharmacotherapy of the ESC

Apelin pathway.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : P Ponikowski (Wroclaw,PL)
  • Joint Session with the working group on pharmacotherapy of the ESC

Omecaptiv.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : J Cleland (Glasgow,GB)
  • Joint Session with the working group on pharmacotherapy of the ESC

Vericiguat.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : B Pieske (Berlin,DE)
  • Joint Session with the working group on pharmacotherapy of the ESC

Nitroxyl donors.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : V Mitrovic (Bad Nauheim,DE)
  • Joint Session with the working group on pharmacotherapy of the ESC

B3 agonists.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : JL Balligand (Brussels,BE)
  • Joint Session with the working group on pharmacotherapy of the ESC

Potassium binders.

Event : Heart Failure 2019

  • Session : Emerging therapies in heart failure
  • Speaker : S Anker (Berlin,DE)
  • Joint Session with the working group on pharmacotherapy of the ESC

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are